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For intracellular Chlamydiaceae, there is no need to withstand osmotic challenges, and
a functional cell wall has not been detected in these pathogens so far. Nevertheless,
penicillin inhibits cell division in Chlamydiaceae resulting in enlarged aberrant bodies,
a phenomenon known as chlamydial anomaly. D-alanine is a unique and essential
component in the biosynthesis of bacterial cell walls. In free-living bacteria like Escherichia
coli, penicillin-binding proteins such as monofunctional transpeptidases PBP2 and PBP3,
the putative targets of penicillin in Chlamydiaceae, cross-link adjacent peptidoglycan
strands via meso-diaminopimelic acid and D-Ala-D-Ala moieties of pentapeptide side
chains. In the absence of genes coding for alanine racemase Alr and DadX homologs,
the source of D-Ala and thus the presence of substrates for PBP2 and PBP3 activity in
Chlamydiaceae has puzzled researchers for years. Interestingly, Chlamydiaceae genomes
encode GlyA, a serine hydroxymethyltransferase that has been shown to exhibit slow
racemization of D- and L-alanine as a side reaction in E. coli. We show that GlyA from
Chlamydia pneumoniae can serve as a source of D-Ala. GlyA partially reversed the
D-Ala auxotrophic phenotype of an E. coli racemase double mutant. Moreover, purified
chlamydial GlyA had racemase activity on L-Ala in vitro and was inhibited by D-cycloserine,
identifying GlyA, besides D-Ala ligase MurC/Ddl, as an additional target of this competitive
inhibitor in Chlamydiaceae. Proof of D-Ala biosynthesis in Chlamydiaceae helps to clarify
the structure of cell wall precursor lipid II and the role of chlamydial penicillin-binding
proteins in the development of non-dividing aberrant chlamydial bodies and persistence
in the presence of penicillin.
Keywords: chlamydial anomaly, persistence, aberrant bodies, D-alanine, alanine racemase, GlyA, penicillin,
D-cycloserine
INTRODUCTION
Acute and chronic diseases caused by Chlamydiaceae are a
global health problem. The Gram-negative obligate intracellu-
lar pathogens depend on eukaryotic host cells to maintain their
unique biphasic developmental cycle. One elusive phenomenon
of the chlamydial biology has fascinated researches for two
decades: for endobacteria, such asChlamydiaceae, there is no need
to resist osmotic challenges and a functional cell wall has not
been detected in these pathogens so far (McCoy and Maurelli,
2006). Nevertheless, in the evolutionary process of adaptation to
the host environment, Chlamydiaceae species conserved in their
reduced genomes a nearly complete cell wall precursor biosyn-
thesis pathway (Figure 1) and antibiotics that target cell wall
biosynthesis are active (McCoy andMaurelli, 2006). Penicillin has
no bactericidal effect, as seen in free-living bacteria, but induces a
reversible state of persistence in Chlamydiaceae that is character-
ized by the formation of viable, enlarged, reticulate bodies. These
persisting cells are called aberrant bodies (AB) and show resis-
tance to azithromycin (Wyrick and Knight, 2004), the first-line
treatment for chlamydial infections (CDC, 2010). Beta-lactam
induced formation of non-dividing ABs has been observed in cell
culture (Skilton et al., 2009) as well as in vivo (Phillips Campbell
et al., 2012).
In free-living bacteria, cell division must be highly coordi-
nated with cell wall biosynthesis to maintain cell integrity. The
need for tightly interconnecting both cell biological processes
may be reflected by the partial overlap of components from both
multi-protein machineries; e.g., the transpeptidase PBP3 (FtsI) is
essential for the incorporation of cell wall building blocks at the
septal cell wall and for cell division.
The bacterial cell wall consists of peptidoglycan, a polymer of
long chains with alternating sugar units of N-acetylglucosamine
(GlcNAc) and N-acetylmuramic acid (MurNAc), which are cross-
linked via flexible peptide bridges. Peptidoglycan is found in
all eubacteria with the exception of some obligate intracellu-
lar species. Biosynthesis of peptidoglycan takes place in three
stages (Figure 1). In the cytoplasm, six enzymes (MurA to MurF)
catalyze the formation of the soluble precursor UDP-MurNAc-
pentapeptide. Notably, the precursor contains D-Ala in positions
4 and 5 of the pentapeptide moiety. D-alanine is a unique and
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FIGURE 1 | Proposed lipid II pathway in Chlamydiaceae. A complete cycle
of lipid II biosynthesis, including translocation to the periplasm, processing and
bactoprenol carrier recycling is required for coordinated function of thedivisome
machinery andmodulation of Nod1 and Nod2mediated host immune response
to chlamydialmuropeptides. Biosynthesis of lipid II takes place in the cytoplasm
and at the inner leaflet of the cytoplasmic membrane. In two consecutive
biosynthesis steps of L-Ala racemization and D-Ala ligation, catalyzed by GlyA
and the MurC/Ddl fusion protein, the D-Ala-D-Ala dipeptide is produced. MurF
adds the dipeptide to the nascent peptide chain to complete synthesis of the
soluble precursor UDP-MurNAc-pentapeptide and to provide D-Ala-D-Ala
moieties in the cell wall precursors for transpeptidation activity of the
penicillin-binding proteins PBP2 and PBP3. Actin-ortholog MreB functionally
organizes MurF, MraY, and MurG (Gaballah et al., 2011), the last three enzymes
in lipid II biosynthesis, at the septum. The synthesized precursor is translocated
to the periplasm and processed by the concerted activity of the PBP enzymes
and amidase AmiA to allow for bactoprenol-P recycling. In the process, the
rudimentary by-product found by Liechti et al. (2013), in which the peptide side
chains are cross-linked by peptide bonds, might result (Ghuysen and Goffin,
1999) and released muropeptides might contribute to modulation of the host
immune response (McCoy and Maurelli, 2006). Chlamydiaceae lack
transglycosylases as well as endopeptidases and pyrophosphorylases
described so far to link lipid II sugar units to form glycan chains, to cleave
peptide bridges between cross-linked glycan chains and to dephosphorylate
bactoprenol-PP, respectively. Moreover, the L-Glu racemase MurI is absent.
Question marks and dashed arrows highlight steps of the pathway that remain
to be clarified. (GlcNAc: N-acetylglucosamine;MurNAc: N-acetylmuramic acid).
essential component in the biosynthesis of bacterial cell walls.
The non-proteinogenic amino acid is synthesized by alanine
racemases Alr and DadX and ligated by Ddl to form D-Ala-
D-Ala. The dipeptide is attached to the amino acid in position
3 by the action of MurF to complete the pentapeptide side
chain. In the first membrane-linked step, MraY catalyzes the syn-
thesis of lipid I by transferring UDP-MurNAc-pentapeptide to
the lipid carrier bactoprenol-phosphate (undecaprenyl-P). With
the addition of UDP-GlcNAc, MurG synthesizes lipid II, the
completed peptidoglycan cell wall building block. Lipid II is then
translocated by the flippase FtsW to the outside of the cell and
incorporated into the peptidoglycan network by the action of
penicillin-binding proteins (PBPs) which exhibit transglycosylase
and DD-transpeptidase activities.
The human cytosolic Pattern Recognition Receptors, Nod1
and Nod2, sensing bacterial cell wall fragments, recognize intra-
cellularC. pneumoniae and subsequentlymediate activation of the
transcription factor NFkB which plays a key role in regulating
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the immune response to infection (McCoy and Maurelli, 2006).
Nod1 and Nod2 receptor mediated recognition, together with
the susceptibilty to penicillin, suggests that cell wall precur-
sors/peptidoglycan fragments are synthesized by Chlamydiaceae
during infection.
A nearly complete lipid II biosynthesis pathway has been
found in genomes of Chlamydiaceae (Figure 1) (McCoy and
Maurelli, 2006), and functional conservation of enzymes catalyz-
ing cytoplasmic steps (MurA, MurC/Ddl, CT390, DapF, MurE,
MurF) and the two membrane-linked steps (MraY and MurG) of
cell wall precursor biosynthesis has been demonstrated (McCoy
and Maurelli, 2006; McCoy et al., 2006; Henrichfreise et al.,
2009; Patin et al., 2009, 2012). Chlamydiaceae genomes code
for only two PBPs that serve as DD-transpeptidases in free-
living bacteria. PBP2 and PBP3 are the putative targets of peni-
cillin in Chlamydiaceae and cross-link adjacent peptidoglycan
strands via meso-diaminopimelic acid and D-Ala-D-Ala moi-
eties in E. coli. AmiA is the only ortholog of septal peptidoglycan
hydrolyzing amidases found in chlamydial genomes. Moreover,
Chlamydiaceae harbor a rudimentary set of cell division pro-
teins, lacking the central organizer FtsZ, but comprising FtsW,
FtsI (PBP3) and FtsK, and possess, despite their spherical shape,
the cytoskeletal protein MreB (Gaballah et al., 2011). Chlamydial
MreB was shown to interact with key components in lipid II
biosynthesis and FtsK (Gaballah et al., 2011; Ouellette et al.,
2012).
We proposed that retaining biosynthesis of lipid II in cell
wall-lacking “minimal bacteria,” like Chlamydiaceae, may reflect
a vital role of the lipid II pathway in prokaryotic cell division
(Henrichfreise et al., 2009). Moreover, we discussed a model
for the role of the conserved lipid II pathway in maintaining
a functional divisome and contributing to modulation of host
response in Chlamydiaceae (Figure 1). A recent study revealed the
presence of cell wall sacculi in Protochlamydia, a genus of evo-
lutionary older amoeba symbionts with less reduced genomes
as compared to Chlamydiaceae (Pilhofer et al., 2013). In the
pathogenic Chlamydiaceae, however, no functional cell wall but
ring-like shaped structures were found and supposed to con-
tain peptidoglycan-like material and localize to the division plane
(Liechti et al., 2013). These findings are consistent with ourmodel
described above which implicates a crucial function of the PBP2
and PBP3 DD-transpeptidase activity in lipid II processing and
sustaining a complete cycle of lipid II biosynthesis and recycling.
PBP catalyzed DD-transpeptidation depends on the presence of
the D-Ala-D-Ala terminus in the pentapeptide side chain of cell
wall building blocks. Genomes of Chlamydiaceae do not encode
homologs of the pyridoxal-5′-phosphate (PLP) cofactor requiring
alanine racemases Alr and DadX. Therefore, the source of D-Ala
and thus the presence of substrates for PBP2 and PBP3 activity in
Chlamydiaceae have remained unclear for years.
We searched chlamydial genomes for genes encoding other
PLP dependent proteins and found serine hydroxymethyltrans-
ferase GlyA to be conserved in all chlamydial genera. Serine
hydroxymethyltransferases are found in eu- and prokaryotes and
are well known for their function in reversible interconversion
of serine and glycine using tetrahydrofolate as the one-carbon
carrier. In addition, the enzymes show a particularly broad
reaction specificity and catalyze other side reactions typical for
PLP dependent enzymes, such as decarboxylation, transamina-
tion and retroaldol cleavage (Contestabile et al., 2001). Moreover,
an alanine racemase co-activity was proven in vitro for GlyA from
E. coli (Shostak and Schirch, 1988).
The aim of this study was to analyze GlyA as a potential source
of D-Ala in Chlamydiaceae.
Here, we demonstrate that GlyA from C. pneumoniae is capa-
ble of the racemization of alanine in vivo and in vitro implicating
that the enzyme can substitute for the absent alanine racemases
and that D-Ala is self-synthesized in Chlamydiaceae.
RESULTS
RACEMIZATION OF ALANINE IN CHLAMYDIAE
Using BLAST alignments, we searched Chlamydiaceae and envi-
romental chlamydiae genomes to identify genes coding for
orthologs of E. coli PLP cofactor-requiring enzymes known to
confer alanine racemization activity (Table 1). In contrast to the
Chlamydiaceae and Simkania, the three environmental chlamy-
diae genera Parachlamydia, Protochlamydia, and Waddlia har-
bored one ortholog of the Alr or DadX alanine racemases. GlyA
Table 1 | PLP cofactor-requiring enzymes involved in biosynthesis of D-Ala.
E. coli Cpn Ctr Pac Pam Wch Sne
Alr (alanine racemase) – – – pc0631
(3e–34)
wcw_0679
(1e–32)
–
DadX (alanine racemase 2) – – PUV_23750
(2e–28)
– – –
GlyA (serine
hydroxymethyltransferase)
CPn0521
(2e–107)
CT432
(2e–108)
PUV_05830
(6e–118)
pc0444
(3e–107)
wcw_1457
(2e–117)
SNE_A20
270
(1e–114)
MetC (cystathionine
beta-lyase)
– – PUV_18690
(2e–40)
– wcw_1145
(4e–40)
–
Locus tags of genes coding for enzymes involved in biosynthesis of D-Ala are shown for two exemplary Chlamydiaceae and for environmental chlamydiae species.
The expected (E) values of BLAST P alignments are listed in brackets. E. coli, Escherichia coli W3110 (NC_007779.1); Cpn, Chlamydia pneumoniae CWL029
(NC_000922); Ctr, Chlamydia trachomatis D/UW-3/Cx (NC_000117); Pac, Parachlamydia acanthamoebae UV-7 (NC_015702.1); Pam, Protochlamydia amoebophila
UWE25 (NC_005861.1); Wch, Waddlia chondrophila WSU 86-1044 (NC_014225.1); Sne, Simkania negevensis Z (NC_015713.1).
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FIGURE 2 | GlyACp exhibits in vivo activity in an E. coli racemase
double mutant. A temperature sensitive alrdadX E. coli double
mutant was transformed with pET21b-glyACp to allow for the
expression of GlyACp in the cytoplasm. Independently generated
transformants (1–3 containing pET21b-glyACp and 4–6 containing the
empty vector) were grown on solid (A) or in liquid (B) LB medium
under limited D-Ala growth conditions at 42◦C. LB medium was
supplemented with 5mg/L D-Ala, 50μM of cofactor PLP, 25μg/ml
thymine and 50μg/ml ampicillin. Expression of GlyACp was induced
by the addition of 0.1mM IPTG.
was the only enzyme to be encoded in Chlamydiaceae and in all
enviromental chlamydiae.
IN VIVO ACTIVITY OF GlyA FROM C. pneumoniae
In the absence of a tractable system to genetically manipulate
C. pneumoniaewe tested whether heterologous expressedC. pneu-
moniae GlyA (GlyACp) shows an effect on the D-Ala auxotrophic
phenotype of an E. coli alrdadX racemase double mutant
strain. Our experiments in liquid and solid culture revealed that
chlamydial GlyA did not completely reverse the need of exoge-
nous D-Ala of the racemase mutant strain but favored its growth
under D-Ala limited conditions (Figure 2). These findings sug-
gest that GlyACp is a functional alanine racemase and capable of
generating D-Ala in E. coli.
RECOMBINANT GlyACp HAS L-ALANINE RACEMASE ACTIVITY
To investigate the potential alanine racemase activity of the
serine hydroxymethyltransferase GlyA from C. pneumoniae, we
overexpressed recombinant GlyACp in E. coli and purified the
Strep-tagged protein. In vitro activity of GlyACp was tested in a D-
amino acid oxidase coupled enzymatic assay containing L-Ala and
cofactor PLP. Alanine racemase from Bacillus stearothermophilus
served as positive control. D-Ala that was produced by GlyA was
converted to pyruvate by the activity of D-amino acid oxidase
(DAAO) and colorimetrically quantified. The chlamydial GlyA
converted L-Ala to D-Ala in vitro exhibiting weak racemase activ-
ity in comparision to the enzyme from B. stearothermophilus
(Figure 3).
GlyACp RACEMASE ACTIVITY IS SENSITIVE TO D-CYCLOSERINE
D-cycloserine is a structural analog of D-Ala and competitively
inhibits activity of alanine racemases and D-Ala ligases from free-
living bacteria (Strominger et al., 1960; Lambert and Neuhaus,
1972). The inhibitor has anti-chlamydial activity in chick embryo
yolk sac infection (Moulder et al., 1963) which can be reversed
by the addition of D-Ala. For the C. trachomatis D-Ala lig-
ase Ddl which is encoded as a fusion with MurC, as typical
for Chlamydiaceae, sensitivity to D-cycloserine has been proven
FIGURE 3 | The purified serine hydroxymethyltransferase GlyACp has
alanine racemase activity. In vitro activity of recombinant GlyACp was
tested in a coupled enzymatic assay containing L-Ala and cofactor PLP. D-Ala
that was produced by 1μg GlyA or Bst racemase was converted to pyruvate
by the activity of DAAO and colorimetrically quantified. (DCS: D-cycloserine;
Bst racemase: alanine racemase from B. stearothermophilus).
before (McCoy andMaurelli, 2005). We performed activity assays
for GlyACp in the presence of D-cycloserine and identified the
enzyme to be a second target of D-cycloserine in Chlamydiaceae
(Figure 3).
DISCUSSION
The source of D-Ala in Chlamydiaceae and thus the presence
of the transpeptidation substrates for PBPs is a crucial aspect
of the chlamydial anomaly that will help to gain understanding
of the penicillin induced persistence in these human pathogens.
Penicillin and other beta-lactams structurally mimic the D-Ala-
D-Ala terminus of the pentapeptide side chain of the lipid
II cell wall building blocks and are recognized by the active
sites of DD-transpeptidase PBPs. Beta-lactams are active against
Chlamydiaceae in cell culture (McCoy andMaurelli, 2006; Skilton
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et al., 2009) and in vivo (Phillips Campbell et al., 2012) and the
chlamydial monofunctional DD-transpeptidases PBP2 and PBP3,
recovered in detergent-soluble fractions from whole cell prepa-
rations, bind [H3]-penicillin (Barbour et al., 1982). Moreover,
the recombinant MurC/Ddl protein from C. trachomatis has been
shown to specifically ligate D-Ala but not the L-Ala enantiomer
to form alanine dipeptides and MurF was demonstrated to add
these D-Ala-D-Ala dipeptides to the lipid II peptide side chain
(McCoy and Maurelli, 2006; Patin et al., 2012). Moulder et al.
(1963) proved anti-chlamydial activity of D-cycloserine in chick
embryo yolk sac infection models and demonstrated the spe-
cific reversal of this effect by the addition of D-alanine (Moulder
et al., 1963). D-cycloserine is a structural analog of D-Ala and well
known as competitive inhibitor of alanine racemases and the D-
Ala ligase Ddl in other bacteria (Strominger et al., 1960; Lambert
and Neuhaus, 1972). Finally, feeding of replicating Chlamydia
trachomatis with D-Ala-D-Ala probes revealed evidence for the
incorporation of D-Ala into ring-like shaped peptidoglycan-like
structures (Liechti et al., 2013). All in all, these data strongly indi-
cate that D-Ala is present in the cells of Chlamydiaceae and plays
an essential role in chlamydial cell biology. In the past, the mam-
malian host was discussed as a potential source of D-Ala (McCoy
and Maurelli, 2006) and in Chlamydiaceae genomes a D-alanine
permease (DagA_2) was annotated (Stephens et al., 1998) that
could allow for the passive transport of D-Ala over the chlamydial
cytoplasmic membrane. Though D-Ala is found almost exclu-
sively in the microbial world and is not synthesized in mam-
malian cells, D-Ala was detected in trace quantities inmammalian
urine and tissues, apparently due to breakdown products from
intestinal and food bacteria (Guoyao, 2013). Nevertheless, exper-
iments with Listeria monocytogenes and Shigella flexneri indicated
that mammalian host cells cannot serve as source of D-Ala.
Alanine racemase knockout mutants of both facultative intracel-
lular species failed to survive within mammalian host cells unless
exogenous D-Ala was added to the cell culture medium (McCoy
and Maurelli, 2006). Based on these data, self-biosynthesis of D-
Ala by alternative racemase activity is more likely the source of
D-Ala in Chlamydiaceae.
For E. coli, besides the constitutive expressed Alr racemase and
the catabolic DadX racemase, two other PLP dependent enzymes
involved in the methionine pathway have been shown to confer L-
Ala racemization as a side reaction. Overexpressed cystathionine
beta-lyase MetC completely reversed the D-Ala auxotrophic phe-
notype of an E. coli racemase double mutant whereas racemase
co-activity of serine hydroxymethyltransferase GlyA was not suf-
ficient to allow for growth on D-Ala lacking medium (Kang et al.,
2011). Recently, in vitro activity of MetC from Wolbachia indi-
cated that the enzyme substitute for the absent alanine racemases
in these endosymbionts of many arthropods and filarial nema-
todes. Wolbachia are excellent targets for anti-filarial therapy.
Similar toChlamydiaceae, these obligate intracellular bacteria lack
a cell wall but treatment with lipid II biosynthesis blocking fos-
fomycin, results in enlargedWolbachia cells (Vollmer et al., 2013).
Among the Chlamydiales only the environmental Parachlamydia
and Waddlia possess a MetC ortholog but all chlamydial gen-
era harbor GlyA. The serine hydroxymethyltransferase is the
only component of the methionine pathway that is encoded by
Chlamydiaceae genomes and phylogenetic analysis indicated lat-
eral transfer of the glyA gene from Actinobacteria to the common
ancestor of Chlamydiales (Griffiths and Gupta, 2006). Moreover,
transcription profiles revealed overlapping expression of the genes
encoding GlyA, enzymes for lipid II biosynthesis (MurA to MurF,
MraY, andMurG) as well as processing (PBP2, PBP3, and AmiA),
the structural protein MreB, and the cell division proteins FtsW
and FtsK (Belland et al., 2003). These data suggest an essential
function of GlyA in chlamydial biology and correlation with the
cellular processes of lipid II biosynthesis and cytokinesis.
We demonstrated L-Ala racemase activity for the GlyA enzyme
from C. pneumoniae in vivo in an E. coli racemase double
mutant and characterized the purified protein in vitro. Moreover,
we identified GlyA as a second target of D-cycloserine besides
MurC/Ddl in Chlamydiaceae.
Our results implicate that the enzyme can substitute for
the absent alanine racemases and that D-Ala is present and
self-synthesized in Chlamydiaceae. The observed weak alanine
racemase activity of GlyACp cannot completely compensate D-Ala
requirements of the E. coli racemase mutant to build a functional
cell wall but might be sufficient to produce D-Ala in amounts
that maintain the lipid II biosynthesis pathway in the cell wall-
lacking Chlamydiaceae for the proposed functions of the cell wall
precursor in co-ordination of cell division and modulation of
the host immune response. Future research toward the elucida-
tion of the chlamydial anomaly will include the isolation and
structural characterization of lipid II building blocks and bio-
chemical analysis of the penicillin binding proteins PBP2 and
PBP3, the putative targets of penicillin whose activity depends
on the presence of D-Ala-D-Ala in the pentapeptide side chain of
lipid II.
Like other effectors, such as interferon-γ and tumor necrosis
factor-α, penicillin can be used to induce persistence as an exper-
imental tool to study chlamydiae/host interactions. Knowledge
of the underlying mechanisms of penicillin induced formation
of ABs will help to assess these results on the pathogenicity of
Chlamydiaceae.
Moreover, analysis of the molecular biology of penicillin
induced persistence is important to improve understanding of
long-term infection in patients in particular as to the role of
chlamydial cell wall precursors in immune modulation and
refractory of ABs to anti-chlamydial agents.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS
E. coli JM83 harboring the GlyACp expression vector was grown
on Luria Bertani (LB) agar plates containing 30μg/ml chloram-
phenicol and 100μg/ml ampicillin, respectively. The temperature
sensitive E. colialrdadX racemase double mutant TKL-10 was
maintained on LB agar plates containing 25μg/ml thymine.
IN VIVO COMPLEMENTATION
E. coli TKL-10alrdadX was transformed with pET21b-glyACp
and grown in liquid or on solid LB medium supplemented with 5
mg/L D-Ala, 50μM PLP, 25μg/ml thymine, 50μg/ml ampicillin
and 0.1mM IPTG at 42◦C. For each experiment three inde-
pendently generated transformants were used and controls with
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E. coli TKL-10 alrdadX harboring the empty pET21b vector
were carried out.
CLONING OF glyA
The glyA gene from C. pneumoniae GiD was amplified by
PCR using primer glyACp_f (5′-ATGGTAGGTCTCAGGCCTT
GCTAAAAGTTTTTGAGAAATTTAAGA-3′) and glyACp_r
(5′-ATGGTAGGTCTCAGCGCTAACTAAAGCTTCTAAATCAAT
TTCAGG-3′) and cloned into pASK-IBA2c (IBA, Germany)
using the BsaI restriction site to generate an N-terminal
OmpA-leader peptide fused, C-terminal Strep-tagged protein
for periplasmic overproduction. For cytoplasmic expression
in complementation assays, glyA was amplified with primers
glyACp_pET21_f (5′-CGTCTTTAGAAGCATATGCTAAAAG-3′)
and glyACp_pET21_r (5′-GTCTCTGCGGCCGCAACTAAAG
CTTC-3′) and cloned into pET21b (Novagen, VWR, Germany)
using NdeI and NotI restriction sites.
OVERPRODUCTION AND PURIFICATION OF GlyACp
E. coli JM83 cells, transformed with pASK-IBA2c-glyACp, were
grown in no salt LB in presence of 30μg/ml of chlorampheni-
col, 250mM sucrose and 50mML-serine at 30◦C. After induction
at an OD600 of 1.2 with 200 ng/ml anhydrotetracyline (AHT),
50μM PLP and 200μM of folinic acid were added and the
cells were incubated for 4 h at 25◦C. The purification of GlyACp
was performed using the protocol for cleared lysates recom-
mended by the manufacturer (IBA, Germany) with small mod-
ifications: the buffers contained 2% N-lauroylsarcosine (or 0.1%
N-lauroylsarcosine in the washing and elution buffer), 2mM 1,4-
dithiothreitol (DTT) and 50μM PLP. Purity of the protein was
controlled using SDS-PAGE.
IN VITRO GlyACp ACTIVITY ASSAY
Racemase activity of GlyACp was determined in a DAAO cou-
pled enzymatic assay system as described previously with slight
modifications (Francois and Kappock, 2007). Briefly, 1μg GlyACp
or DAAO were incubated with 50mM L-alanine in a final vol-
ume of 60μl for 16 h at 37◦C in 50mM KH2PO4, pH 8,
100mMKCl, 80μMPLP and 2mMDTT. D-Ala that was derived
from GlyACp racemization was deaminated into pyruvate by the
activity of DAAO and indirectly quantified by determining the
amount of produced pyruvate with a colorimetric assay using
2,4-dinitrophenylhydrazine (DNPH) as described before (Milner
and Wood, 1976). Alanine racemase from B. stearothermophilus
(Sigma-Aldrich, Germany) was used as positive control. PLP
containing enzymes have been described to show weak transam-
ination activity converting alanine to pyruvate. As a control for
potential L-Ala transamination activity of GlyACp, we ran exper-
iments in the absence of DAAO. No GlyACp catalyzed production
of pyruvate was detected. For GlyACp inhibition assays, 10mM
D-cycloserine was added and both enzymatic steps were carried
out consecutively with a step of heat deactivation in between as
DAAO is sensitive to D-cycloserine inhibition.
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